A June 15 study from U.K.-based Zoe Health examined the symptoms of more than 62,000 positive COVID-19 tests between June 1 and Nov. 27, 2021, when the delta variant was dominant, and Dec. 20, 2021, to Jan. 17, when the omicron variant was dominant.
Three key findings:
- Omicron symptoms lasted for shorter periods than delta symptoms: 6.87 days and 8.89 days, respectively.
- Loss of smell appeared in less than 20 percent of omicron cases and often days after the first symptoms began.
- Omicron is found less frequently in lower respiratory tracts, which can cause severe symptoms.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.